{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T11:44:58Z","timestamp":1791719098439,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Argentina SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chagas is a public health problem, especially in Latin America, exacerbated by migratory movements and increasing urbanization. Argentina is among the countries with the highest estimated prevalence in the region, with 1,500,000 people infected, with mother to child as the main mode of transmission. Vertical transmission has been significantly reduced by treating women of childbearing age; several guidelines in the region recommend treatment as a primary prevention strategy for the child and a secondary prevention strategy for women and their families. Despite recommendations, women of childbearing age are not always treated, and children do not receive timely diagnosis and treatment. The objective of this research was to design an implementation strategy to improve using Chagas guidelines focused on attending women of childbearing age and children at the primary healthcare level and pilot it in three primary health care centers in Argentina.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a pilot feasibility study using the Consolidated Framework for Implementation Research. A qualitative process evaluation was conducted using semi-structured interviews with health care providers and observations in primary health care centers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We developed a multifaceted implementation strategy including training, flowcharts and reminders, a register of suspected and confirmed cases, and the selection of a management facilitator. The pilot study took place between September 2019 and May 2020. The implementation level was heterogeneous and varied depending on the components, being the facilitating factors, the simplicity of the intervention, professionals\u2019 willingness to expand the indication of serologic tests, and staff commitment to the adoption of intervention components. The main barriers found were the change of authorities at the local level, some professionals\u00b4 reluctance to administer etiological treatment, staff shortages, lack of diagnostic supplies, and the health emergency caused by the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Behavioral change strategies should be applied to improve implementation to address some of the main barriers, including support actions offered by opinion leaders, medical experts, and local health authorities. Rapid diagnostic tests should be readily available to maintain behavior changes. We suggest further refinement of the strategy and its implementation in more centers to assess outcomes prospectively with a hybrid implementation research design.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-022-01886-6","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T22:03:01Z","timestamp":1667944981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design and feasibility of an implementation strategy to address Chagas guidelines engagement focused on attending women of childbearing age and children at the primary healthcare level in Argentina: a pilot study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-5432","authenticated-orcid":false,"given":"Karen","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Rouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Belizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Cafferata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Mabel","family":"Berrueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pedro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"1886_CR1","unstructured":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec [Internet]. 2015; (90):[33\u201343 pp.].\u00a0Available from\u00a0http:\/\/www.who.int\/wer\/2015\/wer9006.pdf?ua=1.\u00a0"},{"issue":"7301","key":"1886_CR2","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/nature09221","volume":"465","author":"JR Coura","year":"2010","unstructured":"Coura JR, Vi\u00f1as PA. Chagas disease: a new worldwide challenge. Nature. 2010;465(7301):S6-7.","journal-title":"Nature"},{"issue":"1\u20132","key":"1886_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","volume":"115","author":"GA Schmunis","year":"2010","unstructured":"Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115(1\u20132):14\u201321.","journal-title":"Acta Trop"},{"issue":"15","key":"1886_CR4","first-page":"40","volume":"4","author":"C Spillmann","year":"2013","unstructured":"Spillmann C, Burrone MS, Coto H. An\u00e1lisis de la situaci\u00f3n epidemiol\u00f3gica de la enfermedad de Chagas en Argentina: avances en el control 2012. Rev Argent Salud Publica. 2013;4(15):40\u20134.","journal-title":"Rev Argent Salud Publica."},{"issue":"Suppl 2","key":"1886_CR5","first-page":"29","volume":"38","author":"S Sosa-Estani","year":"2005","unstructured":"Sosa-Estani S. Congenital transmission of Trypanosoma cruzi infection in Argentina. Rev Soc Bras Med Trop. 2005;38(Suppl 2):29\u201332.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"1886_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1590\/S0037-86822009000500002","volume":"42","author":"S Sosa-Estani","year":"2009","unstructured":"Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop. 2009;42(5):484\u20137.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"1886_CR7","doi-asserted-by":"publisher","first-page":"e3312","DOI":"10.1371\/journal.pntd.0003312","volume":"8","author":"DL Fabbro","year":"2014","unstructured":"Fabbro DL, Danesi E, Olivera V, Codeb\u00f3 MO, Denner S, Heredia C, et al. Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014;8(11):e3312.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"1886_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/0074-02760140347","volume":"110","author":"G Moscatelli","year":"2015","unstructured":"Moscatelli G, Moroni S, Garc\u00eda-Bournissen F, Ballering G, Bisio M, Freilij H, et al. Prevention of congenital Chagas through treatment of girls and women of childbearing age. Mem Inst Oswaldo Cruz. 2015;110(4):507\u20139.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1886_CR9","unstructured":"Gu\u00eda para la atenci\u00f3n al paciente infectado con Trypanosoma cruzi (Enfermedad de Chagas) Buenos Aires: Secretar\u00eda de Gobierno de Salud de la Naci\u00f3n; 2018.\u00a0Available from\u00a0https:\/\/bancos.salud.gob.ar\/sites\/default\/files\/2020-01\/chagas-atencion-paciente-infectado-2018.pdf."},{"key":"1886_CR10","unstructured":"Guidelines for the diagnosis and treatment of Chagas disease. Washington, D.C.: Pan American Health Organization; 2019\u00a0Cited Pan American Health Organization.\u00a0Available from\u00a0https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/49653\/9789275120439_eng.pdf."},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"292138","DOI":"10.1155\/2012\/292138","volume":"2012","author":"S Sosa-Estani","year":"2012","unstructured":"Sosa-Estani S, Colantonio L, Segura EL. Therapy of Chagas disease: implications for levels of prevention. J Trop Med. 2012;2012:292138.","journal-title":"J Trop Med"},{"issue":"4","key":"1886_CR12","first-page":"270","volume":"75","author":"S Sosa-Estani","year":"2015","unstructured":"Sosa-Estani S, Altcheh J, Riarte A, Freilij H, Fern\u00e1ndez M. Lineamientos b\u00e1sicos del tratamiento etiol\u00f3gico de enfermedad de Chagas. Medicina (Buenos Aires). 2015;75(4):270\u20132.","journal-title":"Medicina (Buenos Aires)."},{"key":"1886_CR13","first-page":"e20","volume":"41","author":"K Klein","year":"2017","unstructured":"Klein K, Burrone MS, Alonso JP, Ares LR, Mart\u00ed SG, Lavenia A, et al. Estrategia para mejorar el acceso al tratamiento etiol\u00f3gico para la enfermedad de Chagas en el primer nivel de atenci\u00f3n en Argentina. Rev Panam Salud Publica. 2017;41:e20.","journal-title":"Rev Panam Salud Publica."},{"key":"1886_CR14","doi-asserted-by":"publisher","unstructured":"Roberti J, et al. Abordaje de la enfermedad de Chagas en el primer nivel de atenci\u00f3n: investigaci\u00f3n cualitativa en una zona end\u00e9mica de Argentina. Interface - Comunica\u00e7\u00e3o, Sa\u00fade, Educa\u00e7\u00e3o [online]. 2020;24:e200104. Available from: https:\/\/doi.org\/10.1590\/interface.200104.","DOI":"10.1590\/interface.200104"},{"issue":"3","key":"1886_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14787210.2019.1577731","volume":"17","author":"J Alonso-Padilla","year":"2019","unstructured":"Alonso-Padilla J, Cort\u00e9s-Serra N, Pinazo MJ, Bottazzi ME, Abril M, Barreira F, et al. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Rev Anti Infect Ther. 2019;17(3):145\u201357.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"1886_CR16","doi-asserted-by":"publisher","first-page":"e0008782","DOI":"10.1371\/journal.pntd.0008782","volume":"14","author":"RF Damasceno","year":"2020","unstructured":"Damasceno RF, Sabino EC, Ferreira AM, Ribeiro ALP, Moreira HF, Prates TEC, et al. Challenges in the care of patients with Chagas disease in the Brazilian public health system: a qualitative study with primary health care doctors. PLoS Negl Trop Dis. 2020;14(11):e0008782.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"1886_CR17","doi-asserted-by":"publisher","first-page":"e0005770","DOI":"10.1371\/journal.pntd.0005770","volume":"11","author":"M-J Pinazo","year":"2017","unstructured":"Pinazo M-J, Pinto J, Ortiz L, S\u00e1nchez J, Garc\u00eda W, Saravia R, et al. A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform. PLoS Negl Trop Dis. 2017;11(8):e0005770.","journal-title":"PLoS Negl Trop Dis"},{"issue":"18","key":"1886_CR18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMsa071456","volume":"358","author":"F Althabe","year":"2008","unstructured":"Althabe F, Buekens P, Bergel E, Belizan JM, Campbell MK, Moss N, et al. A behavioral intervention to improve obstetrical care. N Engl J Med. 2008;358(18):1929\u201340.","journal-title":"N Engl J Med"},{"key":"1886_CR19","unstructured":"Iniciativa Medicamentos para Enfermedades Olvidadas (DNDi).\u00a0Available from\u00a0http:\/\/www.dndial.org\/es\/dndi-en-america-latina.html.\u00a0"},{"key":"1886_CR20","first-page":"e153","volume":"41","author":"A Marchiol","year":"2017","unstructured":"Marchiol A, Forsyth C, Bernal O, Valencia Hern\u00e1ndez C, Cucunub\u00e1 Z, Pach\u00f3n Abril E, et al. Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia. Rev Panam Salud Publica. 2017;41:e153.","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"1886_CR21","doi-asserted-by":"publisher","first-page":"e001257","DOI":"10.1136\/bmjgh-2018-001257","volume":"4","author":"O Alonge","year":"2019","unstructured":"Alonge O, Rodriguez DC, Brandes N, Geng E, Reveiz L, Peters DH. How is implementation research applied to advance health in low-income and middle-income countries? BMJ Glob Health. 2019;4(2):e001257.","journal-title":"BMJ Glob Health"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"1886_CR23","unstructured":"Qualitative Research in Implementation Science. Division of Cancer Control and Population Sciences: U.S. National Institutes of Health, National Cancer Institute; 2019.\u00a0Available from\u00a0https:\/\/cancercontrol.cancer.gov\/sites\/default\/files\/2020-09\/nci-dccps-implementationscience-whitepaper.pdf."},{"key":"1886_CR24","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.psychres.2019.112516","volume":"280","author":"AB Hamilton","year":"2019","unstructured":"Hamilton AB, Finley EP. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2019;280:112516.","journal-title":"Psychiatry Res"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"i6795","DOI":"10.1136\/bmj.i6795","volume":"356","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI) statement. BMJ. 2017;356:i6795.","journal-title":"BMJ"},{"key":"1886_CR26","unstructured":"Sistema integrado de informaci\u00f3n sanitaria argentina (SIISA).\u00a0Available from\u00a0https:\/\/sisa.msal.gov.ar\/sisa\/#sisa."},{"issue":"8","key":"1886_CR27","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2016.11.004","volume":"69","author":"WV Chan","year":"2017","unstructured":"Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC\/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI implementation science work group: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69(8):1076\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2017.153","volume":"41","author":"A Marchiol","year":"2017","unstructured":"Marchiol A, Forsyth C, Bernal O, Valencia Hern\u00e1ndez C, Cucunub\u00e1 ZM, Pach\u00f3n Abril E, et al. Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia. Rev Panam Salud Publica. 2017;41:1\u20139.","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"1886_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"1886_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12913-018-2938-8","volume":"18","author":"JS Holtrop","year":"2018","unstructured":"Holtrop JS, Rabin BA, Glasgow RE. Qualitative approaches to use of the RE-AIM framework: rationale and methods. BMC Health Serv Res. 2018;18(1):177.","journal-title":"BMC Health Serv Res"},{"key":"1886_CR31","doi-asserted-by":"publisher","unstructured":"Gibbs GR. Analyzing qualitative data. SAGE Publications, Ltd; 2007. https:\/\/doi.org\/10.4135\/9781849208574.","DOI":"10.4135\/9781849208574"},{"key":"1886_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13012-017-0558-z","volume":"12","author":"N VanDevanter","year":"2017","unstructured":"VanDevanter N, Kumar P, Nguyen N, Nguyen L, Nguyen T, Stillman F, et al. Application of the Consolidated Framework for Implementation research to assess factors that may influence implementation of tobacco use treatment guidelines in the Viet Nam public health care delivery system. Implement Sci. 2017;12:27.","journal-title":"Implement Sci"},{"issue":"1","key":"1886_CR33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12889-019-7248-5","volume":"19","author":"AC Pereiro","year":"2019","unstructured":"Pereiro AC, Gold S. Building an innovative Chagas disease program for primary care units, in an urban non- endemic city. BMC Public Health. 2019;19(1):904.","journal-title":"BMC Public Health"},{"issue":"12","key":"1886_CR34","doi-asserted-by":"publisher","first-page":"e01140","DOI":"10.1128\/JCM.01140-20","volume":"58","author":"C Lopez-Albizu","year":"2020","unstructured":"Lopez-Albizu C, Danesi E, Piorno P, Fernandez M, Garc\u00eda Campos F, Scollo K, et al. Rapid diagnostic tests for trypanosoma cruzi infection: field evaluation of two registered kits in a region of endemicity and a region of nonendemicity in Argentina. J Clin Microbiol. 2020;58(12):e01140-20.","journal-title":"J Clin Microbiol."},{"issue":"12","key":"1886_CR35","doi-asserted-by":"publisher","first-page":"e0007877","DOI":"10.1371\/journal.pntd.0007877","volume":"13","author":"D Lozano","year":"2019","unstructured":"Lozano D, Rojas L, M\u00e9ndez S, Casellas A, Sanz S, Ortiz L, et al. Use of rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease \u2013 field implementation in the Bolivian Chaco region. PLoS Negl Trop Dis. 2019;13(12):e0007877.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"1886_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","volume":"21","author":"F Torrico","year":"2021","unstructured":"Torrico F, Gasc\u00f3n J, Barreira F, Blum B, Almeida IC, Alonso-Vega C, et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect Dis. 2021;21(8):1129\u201340.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1886_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12978-020-00972-1","volume":"17","author":"ML Cafferata","year":"2020","unstructured":"Cafferata ML, Toscani MA, Althabe F, Beliz\u00e1n JM, Bergel E, Berrueta M, et al. Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol. Reprod Health. 2020;17(1):128.","journal-title":"Reprod Health"},{"key":"1886_CR38","unstructured":"New Therapies and Biomarkers for Chagas Infection (TESEO). ClinicalTrials.gov Identifier: NCT03981523 U.S.: National Library of Medicine 2019.\u00a0Available from\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03981523."},{"key":"1886_CR39","unstructured":"New Scheme for Treatment With Benznidazole (NuestroBen). ClinicalTrials.gov Identifier: NCT04897516 U.S.: National Library of Medicine 2021.\u00a0Available from\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04897516?term=NuestroBen&draw=2&rank=1."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-022-01886-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T22:05:24Z","timestamp":1667945124000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-022-01886-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/s12875-022-01886-6","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Health Sciences Research Bioethics Committee of the Faculty of Medicine of the Universidad Nacional del Nordeste (Resolution 37\/18). Informants' participation was voluntary, and all participating health professionals signed an informed consent form. Researchers maintained the confidentiality of collected information, under National Act 25.326, on Personal Data Protection of the Argentine Republic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}